ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-12.2x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1938.67% |
| Q3 2025 | -127.84% |
| Q2 2025 | -65.32% |
| Q1 2025 | 181.21% |
| Q4 2024 | 173.33% |
| Q3 2024 | 54.19% |
| Q2 2024 | -249.79% |
| Q1 2024 | 61.59% |
| Q4 2023 | -21.28% |
| Q3 2023 | 31.87% |
| Q2 2023 | 40.40% |
| Q1 2023 | -38.80% |
| Q4 2022 | -154.61% |
| Q3 2022 | 4.25% |
| Q2 2022 | -233.29% |
| Q1 2022 | 592.38% |
| Q4 2021 | -49.83% |
| Q3 2021 | 4.71% |
| Q2 2021 | 131.98% |
| Q1 2021 | -333.49% |
| Q4 2020 | 158.53% |
| Q3 2020 | 57.84% |
| Q2 2020 | -526.33% |
| Q1 2020 | 60.62% |
| Q4 2019 | 38.22% |
| Q3 2019 | 19.85% |
| Q2 2019 | -533.74% |
| Q1 2019 | 113.74% |
| Q4 2018 | -320.87% |
| Q3 2018 | 68.69% |
| Q2 2018 | -261.05% |
| Q1 2018 | -13.40% |
| Q4 2017 | 42.54% |
| Q3 2017 | -55.39% |
| Q2 2017 | -137.38% |
| Q1 2017 | 1829.15% |
| Q4 2016 | -13.15% |
| Q3 2016 | 480.88% |
| Q2 2016 | -102.02% |
| Q1 2016 | 56.66% |